154 related articles for article (PubMed ID: 15808485)
1. Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase.
Hakogi T; Fujii S; Morita M; Ikeda K; Katsumura S
Bioorg Med Chem Lett; 2005 Apr; 15(8):2141-4. PubMed ID: 15808485
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a nitrogen analogue of sphingomyelin as a sphingomyelinase inhibitor.
Hakogi T; Taichi M; Katsumura S
Org Lett; 2003 Aug; 5(16):2801-4. PubMed ID: 12889878
[TBL] [Abstract][Full Text] [Related]
3. Stereocontrolled synthesis of a sphingomyelin methylene analogue as a sphingomyelinase inhibitor.
Hakogi T; Monden Y; Iwama S; Katsumura S
Org Lett; 2000 Aug; 2(17):2627-9. PubMed ID: 10990413
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of sphingomyelin carbon analogues as sphingomyelinase inhibitors.
Hakogi T; Monden Y; Taichi M; Iwama S; Fujii S; Ikeda K; Katsumura S
J Org Chem; 2002 Jul; 67(14):4839-46. PubMed ID: 12098296
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis of phosphonate analogs of sphingomyelins and preparation of an affinity sorbent for sphingomyelinase purification].
Tazabekova NT; Bushnev AS; Kakimzhanova ZhA; Zvonkova EN; Evstigneeva RP
Bioorg Khim; 1987 May; 13(5):648-53. PubMed ID: 3040014
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis.
Oda M; Imagawa H; Kato R; Yabiku K; Yoshikawa T; Takemoto T; Takahashi H; Yamamoto H; Nishizawa M; Sakurai J; Nagahama M
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):303-10. PubMed ID: 23488740
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiapoptotic activity of a novel analogue of the neutral sphingomyelinase inhibitor scyphostatin.
Claus RA; Wüstholz A; Müller S; Bockmeyer CL; Riedel NH; Kinscherf R; Deigner HP
Chembiochem; 2005 Apr; 6(4):726-37. PubMed ID: 15751001
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase.
Yokomatsu T; Takechi H; Akiyama T; Shibuya S; Kominato T; Soeda S; Shimeno H
Bioorg Med Chem Lett; 2001 May; 11(10):1277-80. PubMed ID: 11392536
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Sugimoto K; Goda K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Jun; 13(12):1963-6. PubMed ID: 12781174
[TBL] [Abstract][Full Text] [Related]
11. An improved assay method for the measurement and detection of sphingomyelinase activity.
Taki T; Chatterjee S
Anal Biochem; 1995 Jan; 224(2):490-3. PubMed ID: 7733450
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol modulation of sphingomyelinase activity at physiological temperatures.
Contreras FX; Sot J; Ruiz-Argüello MB; Alonso A; Goñi FM
Chem Phys Lipids; 2004 Jul; 130(2):127-34. PubMed ID: 15172829
[TBL] [Abstract][Full Text] [Related]
13. [The enzymatic analysis of sphingomyelin in HDL (author's transl)].
Schriewer H; Jabs HU; Assmann G
J Clin Chem Clin Biochem; 1982 May; 20(5):305-12. PubMed ID: 6809883
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelinase cleavage of sphingomyelin in pure and mixed lipid membranes. Influence of the physical state of the sphingolipid.
Ruiz-Argüello MB; Veiga MP; Arrondo JL; Goñi FM; Alonso A
Chem Phys Lipids; 2002 Jan; 114(1):11-20. PubMed ID: 11841822
[TBL] [Abstract][Full Text] [Related]
15. Diastereoselective synthesis of gamma-amino-delta-hydroxy-alpha,alpha-difluorophosphonates: a vehicle for structure-activity relationship studies on SMA-7, a potent sphingomyelinase inhibitor.
Yamagishi T; Muronoi S; Hikishima S; Shimeno H; Soeda S; Yokomatsu T
J Org Chem; 2009 Aug; 74(16):6350-3. PubMed ID: 19610607
[TBL] [Abstract][Full Text] [Related]
16. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
Wascholowski V; Giannis A
Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
[No Abstract] [Full Text] [Related]
17. Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Goda K; Sugimoto K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Nov; 13(21):3681-4. PubMed ID: 14552757
[TBL] [Abstract][Full Text] [Related]
18. Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.
Boulgaropoulos B; Amenitsch H; Laggner P; Pabst G
Biophys J; 2010 Jul; 99(2):499-506. PubMed ID: 20643068
[TBL] [Abstract][Full Text] [Related]
19. Concise asymmetric total synthesis of scyphostatin, a potent inhibitor of neutral sphingomyelinase.
Fujioka H; Sawama Y; Kotoku N; Ohnaka T; Okitsu T; Murata N; Kubo O; Li R; Kita Y
Chemistry; 2007; 13(36):10225-38. PubMed ID: 17907134
[TBL] [Abstract][Full Text] [Related]
20. His151 and His296 are the acid-base catalytic residues of Bacillus cereus sphingomyelinase in sphingomyelin hydrolysis.
Obama T; Fujii S; Ikezawa H; Ikeda K; Imagawa M; Tsukamoto K
Biol Pharm Bull; 2003 Jul; 26(7):920-6. PubMed ID: 12843611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
